Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population.
Kemnade JO, Florez M, Sabichi A, Zhang J, Jhaveri P, Chen G, Chen A, Miller-Chism C, Shaun B, Hilsenbeck SG, Hernandez DJ, Skinner HD, Sandulache VC.
Kemnade JO, et al.
Oral Oncol. 2023 Oct;145:106536. doi: 10.1016/j.oraloncology.2023.106536. Epub 2023 Aug 8.
Oral Oncol. 2023.
PMID: 37562095